June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Preliminary evaluation of hyperopic SMILE in amblyopic eyes
Author Affiliations & Notes
  • Dan Z Reinstein
    London Vision Clinic, London, United Kingdom
    Columbia University Medical Center, New York, NY
  • Kishore Pradhan
    Refractive Surgery Unit, Tilganga Institute of Ophthalmology, Kathmandu, Nepal
  • Glenn Ian Carp
    London Vision Clinic, London, United Kingdom
  • Timothy J Archer
    London Vision Clinic, London, United Kingdom
  • Marine Gobbe
    London Vision Clinic, London, United Kingdom
  • Raynan Khan
    London Vision Clinic, London, United Kingdom
  • Footnotes
    Commercial Relationships Dan Reinstein, Carl Zeiss Meditec (C); Kishore Pradhan, None; Glenn Carp, None; Timothy Archer, None; Marine Gobbe, None; Raynan Khan, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3928. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dan Z Reinstein, Kishore Pradhan, Glenn Ian Carp, Timothy J Archer, Marine Gobbe, Raynan Khan; Preliminary evaluation of hyperopic SMILE in amblyopic eyes. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3928.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To evaluate optical quality and centration outcome measures of small incision lenticule extraction (SMILE) for hyperopia.

 
Methods
 

This was a prospective ethical committee approved study for eyes with hyperopic astigmatism treated by SMILE using the VisuMax femtosecond laser (Carl Zeiss Meditec). Study inclusion criteria were a maximum intended sphere up to +7 D with astigmatism up to 6 D, age ≥21 years, CDVA 20/100 or worse. Optical zone was centered on the corneal vertex and fixed at 6.3 mm with a 2 mm transition zone, 30 μm minimum lenticule thickness, and 120 μm cap thickness. Retinoscopic refraction and Atlas topography were obtained before and 1 month after surgery. Twenty eyes were included and 1 month data were available in 11 eyes at the time of writing. Refractive predictability, optical zone centration, achieved optical zone diameter (assessed by tangential curvature difference maps to the mid-peripheral power inflection point), and change in corneal spherical aberration (6 mm) were analyzed. MEL80 corneal vertex centered LASIK eyes matched for sphere and cylinder (±0.50 D) were randomly mined from our database to make 2 control groups: optical zone 6.5 mm or 7 mm (both transition 2 mm).

 
Results
 

Mean SEQ was +4.68±1.30 D (+3.00 to +6.42 D). Mean refractive astigmatism was 1.09±0.65 D (0.50 to 2.75 D). Mean postop SEQ was +0.10±0.91 D (-1.16 to +1.50 D); 27% ±0.50 D and 82% ±1.00 D. Mean spherical aberration change was -0.49 μm in the 6.3 mm SMILE group, found to be equivalent to the 7 mm LASIK group (-0.47 μm, p=0.916), but less than the 6.5 mm LASIK group (-0.79 μm, p=0.002). Mean optical zone offset was equal for all groups (p>0.73); 0.30±0.18 mm in the 6.3 mm SMILE group, 0.34±0.26 mm in the 7 mm LASIK group, and 0.29±0.15 mm in the 6.5 mm LASIK group. Mean achieved optical zone diameter was 5.55±0.35 mm in the 6.3 mm SMILE group; larger than the 6.5 mm LASIK group (4.65±0.18 mm, p<0.001) and the 7 mm LASIK group (4.93±0.32 mm, p<0.001).

 
Conclusions
 

Optical zone centration was equivalent between vertex centered hyperopic SMILE and LASIK. Less spherical aberration was induced by 6.3 mm SMILE than 6.5 mm LASIK and was equivalent to 7 mm LASIK. Achieved topographic optical zone diameter was larger for 6.3 mm SMILE than 6.5 and 7 mm LASIK. Refraction change by retinoscopy appeared relatively accurate although longer term sighted eye studies will be required to refine nomograms and balance these with observed regression.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×